Is SHEL a buy, hold, or sell?
SHEL carries a valuation grade of Strong Buy. The trailing P/E of 12.7 sits broadly in line with the Energy sector median of 12.0x. Our discounted cash flow model produces an intrinsic range of $92–$166 — implying a +58% margin of safety at the current price of $81.40. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 10.2% earnings surprise. Analyst estimate revisions are trending upward.
What are SHEL's key risk factors?
With a beta of -0.23, SHEL exhibits a low-volatility risk profile relative to the broad market. The 95th-percentile CVaR of -9.6% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.0% of total portfolio loss in the worst 5% of months. Net margins of 7.0% fall below the Energy sector average of 10%, suggesting margin pressure. The balance sheet is conservatively leveraged at 43% debt-to-equity.
At 0.10, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 39.5% exceeds realized volatility of 27.8% by 12 points, suggesting options are pricing in elevated risk. Short interest is low at 2.0% of float, suggesting limited bearish conviction.
How does SHEL fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — SHEL carries a beta of -0.23, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, SHEL shows the strongest co-movement with BP (0.77), XOM (0.67), CVX (0.64). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.77, adding SHEL to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The SHEL analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning SHEL’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
